Skip to main content
Top
Published in: Archives of Virology 12/2014

Open Access 01-12-2014 | Original Article

Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004–2007 and 2008–2011

Authors: Xia Rong, Ru Xu, Huaping Xiong, Min Wang, Ke Huang, Qiuyu Chen, Chengyao Li, Qiao Liao, Jieting Huang, Wenjie Xia, Guangping Luo, Xin Ye, Ming Zhang, Yongshui Fu

Published in: Archives of Virology | Issue 12/2014

Login to get access

Abstract

Different hepatitis C virus (HCV) genotypes exhibit differences in disease pathogenesis and progression, as well as disease outcomes and response to therapy. Tracking the change of HCV genotypes in various epidemiological settings is critical for both disease surveillance and the development of improved antiviral treatment. Here, we tracked the changes in the prevalence of the HCV genotypes in China between 2004-2007 and 2008-2011. HCV-RNA-positive sera were collected from volunteer blood donors during the period 2008-2011. The genotypes were determined by phylogenic analysis using the NS5B and E1 sequences. Geographical and demographic distribution patterns related to the HCV genotypes obtained in 2008-2011 were compared with our previous study, which recorded data in the period 2004-2007. Pearson chi-square test and t-test were used to statistically analyze the results. In 2008-2011, HCV subtypes 1b and 6a were detected in 43.8 % (184/420) and 34.3 % (144/420), respectively. The male/female ratio was found to be higher for HCV genotype 6 than for genotypes 1 and 2. When compared with the period of 2004-2007, although no significant difference was found in gender or age for genotypes 1, 2, 3 and 6, the subtype 6a frequency was significantly increased from 11 % to 26.5 % in the blood donors from outside of Guangdong Province in 2008-2011. A pattern of increase in HCV subtype 6a was found in blood donors outside of Guangdong Province, indicating that HCV subtype 6a has rapidly spread from Guangdong to other regions of China over the past 10 years.
Appendix
Available only for authorised users
Literature
1.
go back to reference Global Burden of Hepatitis C Working Group (2004) Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 44(1):20–29 Global Burden of Hepatitis C Working Group (2004) Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 44(1):20–29
2.
go back to reference Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P (2014) Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource. Hepatology 59:318–327PubMedCentralPubMedCrossRef Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P (2014) Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource. Hepatology 59:318–327PubMedCentralPubMedCrossRef
3.
go back to reference Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin IT, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962–973PubMedCrossRef Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin IT, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962–973PubMedCrossRef
4.
go back to reference Mahaney K, Tedeschi V, Maertens G, Di Bisceglie AM, Vergalla J, Hoofnagle JH, Sallie R (1994) Genotypic analysis of hepatitis C virus in American patients. Hepatology 20:1405–1411PubMedCrossRef Mahaney K, Tedeschi V, Maertens G, Di Bisceglie AM, Vergalla J, Hoofnagle JH, Sallie R (1994) Genotypic analysis of hepatitis C virus in American patients. Hepatology 20:1405–1411PubMedCrossRef
5.
go back to reference Grassi E, Aghemo A (2013) How to optimize HCV therapy in genotype 2 patients. Liver Int 33(Suppl 1):35–40PubMedCrossRef Grassi E, Aghemo A (2013) How to optimize HCV therapy in genotype 2 patients. Liver Int 33(Suppl 1):35–40PubMedCrossRef
6.
go back to reference Lagging M, Rembeck K, Rauning Buhl M, Christensen P, Dalgard O, Farkkila M, Hellstrand K, Langeland N, Lindh M, Westin J, Norkrans G (2013) Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse. Scand J Gastroenterol 48:839–847PubMedCrossRef Lagging M, Rembeck K, Rauning Buhl M, Christensen P, Dalgard O, Farkkila M, Hellstrand K, Langeland N, Lindh M, Westin J, Norkrans G (2013) Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse. Scand J Gastroenterol 48:839–847PubMedCrossRef
7.
go back to reference Abe H, Aida Y, Ishiguro H, Yoshizawa K, Seki N, Miyazaki T, Itagaki M, Sutoh S, Ika M, Kato K, Shimada N, Tsubota A, Aizawa Y (2013) New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection. J Med Virol 85:1523–1533PubMedCrossRef Abe H, Aida Y, Ishiguro H, Yoshizawa K, Seki N, Miyazaki T, Itagaki M, Sutoh S, Ika M, Kato K, Shimada N, Tsubota A, Aizawa Y (2013) New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection. J Med Virol 85:1523–1533PubMedCrossRef
8.
go back to reference Inamullah IM, Ahmed H, Sajidulg AM, Ali L, Ahmed A (2011) Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan. Virol J 8:16PubMedCentralPubMedCrossRef Inamullah IM, Ahmed H, Sajidulg AM, Ali L, Ahmed A (2011) Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan. Virol J 8:16PubMedCentralPubMedCrossRef
9.
go back to reference Chakravarti A, Ashraf A, Malik S (2013) A study of changing trends of prevalence and genotypic distribution of hepatitis C virus among high risk groups in North India. Indian J Med Microbiol 31:354–359PubMedCrossRef Chakravarti A, Ashraf A, Malik S (2013) A study of changing trends of prevalence and genotypic distribution of hepatitis C virus among high risk groups in North India. Indian J Med Microbiol 31:354–359PubMedCrossRef
10.
go back to reference Verbeeck J, Maes P, Lemey P, Pybus OG, Wollants E, Song E, Nevens F, Fevery J, Delport W, Van der Merwe S, Van Ranst M (2006) Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol 80:4220–4226PubMedCentralPubMedCrossRef Verbeeck J, Maes P, Lemey P, Pybus OG, Wollants E, Song E, Nevens F, Fevery J, Delport W, Van der Merwe S, Van Ranst M (2006) Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol 80:4220–4226PubMedCentralPubMedCrossRef
11.
go back to reference Akkarathamrongsin S, Praianantathavorn K, Hacharoen N, Theamboonlers A, Tangkijvanich P, Tanaka Y, Mizokami M, Poovorawan Y (2010) Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand. J Med Virol 82:257–262PubMedCrossRef Akkarathamrongsin S, Praianantathavorn K, Hacharoen N, Theamboonlers A, Tangkijvanich P, Tanaka Y, Mizokami M, Poovorawan Y (2010) Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand. J Med Virol 82:257–262PubMedCrossRef
12.
go back to reference Nguyen NH, Vutien P, Trinh HN, Garcia RT, Nguyen LH, Nguyen HA, Nguyen KK, Nguyen MH (2010) Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans. Hepatol Int 4:523–529PubMedCentralPubMedCrossRef Nguyen NH, Vutien P, Trinh HN, Garcia RT, Nguyen LH, Nguyen HA, Nguyen KK, Nguyen MH (2010) Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans. Hepatol Int 4:523–529PubMedCentralPubMedCrossRef
13.
go back to reference Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH (2005) Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol 75:538–549PubMedCrossRef Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH (2005) Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol 75:538–549PubMedCrossRef
14.
go back to reference Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358:958–965PubMedCrossRef Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358:958–965PubMedCrossRef
15.
go back to reference Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347:975–982PubMedCrossRef Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347:975–982PubMedCrossRef
16.
go back to reference Casey LC, Lee WM (2013) Hepatitis C virus therapy update. Curr Opin Gastroenterol 29:243–249PubMed Casey LC, Lee WM (2013) Hepatitis C virus therapy update. Curr Opin Gastroenterol 29:243–249PubMed
17.
go back to reference Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, Chyczewski L (2008) Changing HCV genotypes distribution in Poland–relation to source and time of infection. J Clin Virol 42:156–159PubMedCrossRef Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, Chyczewski L (2008) Changing HCV genotypes distribution in Poland–relation to source and time of infection. J Clin Virol 42:156–159PubMedCrossRef
18.
go back to reference Ross RS, Viazov S, Renzing-Kohler K, Roggendorf M (2000) Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes. J Med Virol 60:122–125PubMedCrossRef Ross RS, Viazov S, Renzing-Kohler K, Roggendorf M (2000) Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes. J Med Virol 60:122–125PubMedCrossRef
19.
go back to reference Maieron A, Metz-Gercek S, Hackl F, Luger C, Ziachehabi A, Strauss R, Schofl R, Mittermayer H (2010) Chronic hepatitis C in Austria, 1992-2006: genotype distribution and demographic factors. Euro Surveill 15:19492PubMed Maieron A, Metz-Gercek S, Hackl F, Luger C, Ziachehabi A, Strauss R, Schofl R, Mittermayer H (2010) Chronic hepatitis C in Austria, 1992-2006: genotype distribution and demographic factors. Euro Surveill 15:19492PubMed
20.
go back to reference Bourliere M, Barberin JM, Rotily M, Guagliardo V, Portal I, Lecomte L, Benali S, Boustiere C, Perrier H, Jullien M, Lambot G, Loyer R, LeBars O, Daniel R, Khiri H, Halfon P (2002) Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. J Viral Hepat 9:62–70PubMedCrossRef Bourliere M, Barberin JM, Rotily M, Guagliardo V, Portal I, Lecomte L, Benali S, Boustiere C, Perrier H, Jullien M, Lambot G, Loyer R, LeBars O, Daniel R, Khiri H, Halfon P (2002) Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. J Viral Hepat 9:62–70PubMedCrossRef
21.
go back to reference Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M (2011) Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol 21:401–416PubMedCentralPubMedCrossRef Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M (2011) Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol 21:401–416PubMedCentralPubMedCrossRef
23.
go back to reference Ding X, Gu H, Zhong ZH, Zilong X, Tran HT, Iwaki Y, Li TC, Sata T, Abe K (2003) Molecular epidemiology of hepatitis viruses and genotypic distribution of hepatitis B and C viruses in Harbin, China. Jpn J Infect Dis 56:19–22PubMed Ding X, Gu H, Zhong ZH, Zilong X, Tran HT, Iwaki Y, Li TC, Sata T, Abe K (2003) Molecular epidemiology of hepatitis viruses and genotypic distribution of hepatitis B and C viruses in Harbin, China. Jpn J Infect Dis 56:19–22PubMed
24.
go back to reference Nakano T, Lu L, He Y, Fu Y, Robertson BH, Pybus OG (2006) Population genetic history of hepatitis C virus 1b infection in China. J Gen Virol 87:73–82PubMedCrossRef Nakano T, Lu L, He Y, Fu Y, Robertson BH, Pybus OG (2006) Population genetic history of hepatitis C virus 1b infection in China. J Gen Virol 87:73–82PubMedCrossRef
25.
go back to reference Wu RR, Mizokami M, Lau JY, Ohno T, Fang ZX, Ohba K, Wu XS, Hata A, Sasaki M, Iino S (1995) Seroprevalence of hepatitis C virus infection and its genotype in Lanzhou, western China. J Med Virol 45:174–178PubMedCrossRef Wu RR, Mizokami M, Lau JY, Ohno T, Fang ZX, Ohba K, Wu XS, Hata A, Sasaki M, Iino S (1995) Seroprevalence of hepatitis C virus infection and its genotype in Lanzhou, western China. J Med Virol 45:174–178PubMedCrossRef
26.
go back to reference Holland PV, Barrera JM, Ercilla MG, Yoshida CF, Wang Y, de Olim GA, Betlach B, Kuramoto K, Okamoto H (1996) Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method. J Clin Microbiol 34:2372–2378PubMedCentralPubMed Holland PV, Barrera JM, Ercilla MG, Yoshida CF, Wang Y, de Olim GA, Betlach B, Kuramoto K, Okamoto H (1996) Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method. J Clin Microbiol 34:2372–2378PubMedCentralPubMed
27.
go back to reference Hwang SJ, Lee SD, Chan CY, Lu RH, Lo KJ (1994) A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 21:831–836PubMedCrossRef Hwang SJ, Lee SD, Chan CY, Lu RH, Lo KJ (1994) A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 21:831–836PubMedCrossRef
28.
go back to reference Fu Y, Wang Y, Xia W, Pybus OG, Qin W, Lu L, Nelson K (2011) New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors. J Viral Hepat 18:42–52PubMedCentralPubMedCrossRef Fu Y, Wang Y, Xia W, Pybus OG, Qin W, Lu L, Nelson K (2011) New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors. J Viral Hepat 18:42–52PubMedCentralPubMedCrossRef
29.
go back to reference Fu Y, Xia W, Wang Y, Tian L, Pybus OG, Lu L, Nelson K (2010) The seroprevalence of hepatitis C virus (HCV) among 559,890 first-time volunteer blood donors in China reflects regional heterogeneity in HCV prevalence and changes in blood donor recruitment models. Transfusion 50:1505–1511PubMedCentralPubMedCrossRef Fu Y, Xia W, Wang Y, Tian L, Pybus OG, Lu L, Nelson K (2010) The seroprevalence of hepatitis C virus (HCV) among 559,890 first-time volunteer blood donors in China reflects regional heterogeneity in HCV prevalence and changes in blood donor recruitment models. Transfusion 50:1505–1511PubMedCentralPubMedCrossRef
30.
go back to reference Fu Y, Qin W, Cao H, Xu R, Tan Y, Lu T, Wang H, Tong W, Rong X, Li G, Yuan M, Li C, Abe K, Lu L, Chen G (2012) HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses. PLoS One 7:e28006PubMedCentralPubMedCrossRef Fu Y, Qin W, Cao H, Xu R, Tan Y, Lu T, Wang H, Tong W, Rong X, Li G, Yuan M, Li C, Abe K, Lu L, Chen G (2012) HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses. PLoS One 7:e28006PubMedCentralPubMedCrossRef
31.
go back to reference Rong X, Lu L, Wang J, Xiong H, Huang J, Chen J, Huang K, Xu R, Wang M, Zhang X, Guo T, Liu Y, Gao G, Fu Y, Nelson KE (2012) Correlation of viral loads with HCV genotypes: higher levels of virus were revealed among blood donors infected with 6a strains. PLoS One 7:e52467PubMedCentralPubMedCrossRef Rong X, Lu L, Wang J, Xiong H, Huang J, Chen J, Huang K, Xu R, Wang M, Zhang X, Guo T, Liu Y, Gao G, Fu Y, Nelson KE (2012) Correlation of viral loads with HCV genotypes: higher levels of virus were revealed among blood donors infected with 6a strains. PLoS One 7:e52467PubMedCentralPubMedCrossRef
32.
go back to reference Dong ZX, Zhou HJ, Wang JH, Xiang XG, Zhuang Y, Guo SM, Gui HL, Zhao GD, Tang WL, Wang H, Xie Q (2012) Distribution of hepatitis C virus genotypes in Chinese patients with chronic hepatitis C: correlation with patients’ characteristics and clinical parameters. J Dig Dis 13:564–570PubMedCrossRef Dong ZX, Zhou HJ, Wang JH, Xiang XG, Zhuang Y, Guo SM, Gui HL, Zhao GD, Tang WL, Wang H, Xie Q (2012) Distribution of hepatitis C virus genotypes in Chinese patients with chronic hepatitis C: correlation with patients’ characteristics and clinical parameters. J Dig Dis 13:564–570PubMedCrossRef
33.
go back to reference Seto WK, Lai CL, Fung J, Hung I, Yuen J, Young J, Wong DK, Yuen MF (2010) Natural history of chronic hepatitis C: genotype 1 versus genotype 6. J Hepatol 53:444–448PubMedCrossRef Seto WK, Lai CL, Fung J, Hung I, Yuen J, Young J, Wong DK, Yuen MF (2010) Natural history of chronic hepatitis C: genotype 1 versus genotype 6. J Hepatol 53:444–448PubMedCrossRef
34.
go back to reference Li CS, Chan PK, Tang JW (2009) Molecular epidemiology of hepatitis C genotype 6a from patients with chronic hepatitis C from Hong Kong. J Med Virol 81:628–633PubMedCrossRef Li CS, Chan PK, Tang JW (2009) Molecular epidemiology of hepatitis C genotype 6a from patients with chronic hepatitis C from Hong Kong. J Med Virol 81:628–633PubMedCrossRef
36.
go back to reference Yan Z, Fan K, Wang Y, Fan Y, Tan Z, Deng G (2012) Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china. Hepat Mon 12:196–204PubMedCentralPubMedCrossRef Yan Z, Fan K, Wang Y, Fan Y, Tan Z, Deng G (2012) Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china. Hepat Mon 12:196–204PubMedCentralPubMedCrossRef
37.
go back to reference Yue QH, Zhang XQ, Shang Y, Chen YZ, Sun WL, Su MQ, Mu SJ, Hao XK, Hu XB (2010) Anti-HCV reactive volunteer blood donors distribution character and genotypes switch in Xi’an, China. Virol J 7:186PubMedCentralPubMedCrossRef Yue QH, Zhang XQ, Shang Y, Chen YZ, Sun WL, Su MQ, Mu SJ, Hao XK, Hu XB (2010) Anti-HCV reactive volunteer blood donors distribution character and genotypes switch in Xi’an, China. Virol J 7:186PubMedCentralPubMedCrossRef
38.
go back to reference Sulkowski MS, Ray SC, Thomas DL (2002) Needlestick transmission of hepatitis C. Jama 287:2406–2413PubMedCrossRef Sulkowski MS, Ray SC, Thomas DL (2002) Needlestick transmission of hepatitis C. Jama 287:2406–2413PubMedCrossRef
39.
go back to reference Fung J, Lai CL, Hung I, Young J, Cheng C, Wong D, Yuen MF (2008) Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin. J Infect Dis 198:808–812PubMedCrossRef Fung J, Lai CL, Hung I, Young J, Cheng C, Wong D, Yuen MF (2008) Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin. J Infect Dis 198:808–812PubMedCrossRef
40.
go back to reference Hui CK, Yuen MF, Sablon E, Chan AO, Wong BC, Lai CL (2003) Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: a comparison with genotype 1. J Infect Dis 187:1071–1074PubMedCrossRef Hui CK, Yuen MF, Sablon E, Chan AO, Wong BC, Lai CL (2003) Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: a comparison with genotype 1. J Infect Dis 187:1071–1074PubMedCrossRef
41.
go back to reference Nguyen NH, VuTien P, Garcia RT, Trinh H, Nguyen H, Nguyen K, Levitt B, Nguyen MH (2010) Response to pegylated interferon and ribavirin in Asian American patients with chronic hepatitis C genotypes 1 vs 2/3 vs 6. J Viral Hepat 17:691–697PubMedCrossRef Nguyen NH, VuTien P, Garcia RT, Trinh H, Nguyen H, Nguyen K, Levitt B, Nguyen MH (2010) Response to pegylated interferon and ribavirin in Asian American patients with chronic hepatitis C genotypes 1 vs 2/3 vs 6. J Viral Hepat 17:691–697PubMedCrossRef
42.
go back to reference Lam KD, Trinh HN, Do ST, Nguyen TT, Garcia RT, Nguyen T, Phan QQ, Nguyen HA, Nguyen KK, Nguyen LH, Nguyen MH (2010) Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6. Hepatology 52:1573–1580PubMedCrossRef Lam KD, Trinh HN, Do ST, Nguyen TT, Garcia RT, Nguyen T, Phan QQ, Nguyen HA, Nguyen KK, Nguyen LH, Nguyen MH (2010) Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6. Hepatology 52:1573–1580PubMedCrossRef
44.
go back to reference Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, Yu XF (2004) Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 33:182–188PubMedCrossRef Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, Yu XF (2004) Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 33:182–188PubMedCrossRef
45.
go back to reference van de Laar T, Pybus O, Bruisten S, Brown D, Nelson M, Bhagani S, Vogel M, Baumgarten A, Chaix ML, Fisher M, Gotz H, Matthews GV, Neifer S, White P, Rawlinson W, Pol S, Rockstroh J, Coutinho R, Dore GJ, Dusheiko GM, Danta M (2009) Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 136:1609–1617PubMedCrossRef van de Laar T, Pybus O, Bruisten S, Brown D, Nelson M, Bhagani S, Vogel M, Baumgarten A, Chaix ML, Fisher M, Gotz H, Matthews GV, Neifer S, White P, Rawlinson W, Pol S, Rockstroh J, Coutinho R, Dore GJ, Dusheiko GM, Danta M (2009) Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 136:1609–1617PubMedCrossRef
46.
go back to reference Murakami J, Nagata I, Iitsuka T, Okamoto M, Kaji S, Hoshika T, Matsuda R, Kanzaki S, Shiraki K, Suyama A, Hino S (2012) Risk factors for mother-to-child transmission of hepatitis C virus: maternal high viral load and fetal exposure in the birth canal. Hepatol Res 42:648–657PubMedCrossRef Murakami J, Nagata I, Iitsuka T, Okamoto M, Kaji S, Hoshika T, Matsuda R, Kanzaki S, Shiraki K, Suyama A, Hino S (2012) Risk factors for mother-to-child transmission of hepatitis C virus: maternal high viral load and fetal exposure in the birth canal. Hepatol Res 42:648–657PubMedCrossRef
Metadata
Title
Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004–2007 and 2008–2011
Authors
Xia Rong
Ru Xu
Huaping Xiong
Min Wang
Ke Huang
Qiuyu Chen
Chengyao Li
Qiao Liao
Jieting Huang
Wenjie Xia
Guangping Luo
Xin Ye
Ming Zhang
Yongshui Fu
Publication date
01-12-2014
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 12/2014
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-014-2185-1

Other articles of this Issue 12/2014

Archives of Virology 12/2014 Go to the issue

Annotated Sequence Record

Novel dicistrovirus from bat guano